An evidence-based web-app helped children with epilepsy to fall asleep on average 16.5 minutes earlier. A new UK-wide ...

Atacicept is a recombinant fusion protein that binds to and inhibits the activity of BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand).

Takeda & Protagonist submit NDA to US FDA seeking approval for rusfertide to treat polycythemia vera: Osaka, Japan Wednesday, January 7, 2026, 17:00 Hrs [IST] Takeda, focused on c ...

FDA assigned PDUFA target action date of July 7, 2026.If approved, atacicept would be the first B cell modulator targeting both BAFF and APRIL for IgAN.Atacicept received FDA Breakthrough Therapy Desi ...

Gratitude meditation is one of those practices that sounds almost too simple at first - a gentle pause to reflect on what’s ...

The A-Frame—Awareness, Appreciation, Acceptance, and Accountability—offers a psychologically grounded way to respond to this ...

In subjects with elevated cardiovascular disease (CVD) risk, MRT-8102, a NEK7-directed molecular glue degrader in development for the treatment of NLRP3/IL-1/IL-6 driven inflammatory diseases, demonst ...

An AI model that learns without human input—by posing interesting queries for itself—might point the way to superintelligence. Save this story Save this story Even the smartest artificial intelligence ...

Recall has a a powerful AI assistant which you can prompt for summaries, key points, insights, information retrieval, ...

In the modern educational landscape, students have more tools at their disposal than ever before. Technology has revolutionized the way learners interact with content, practice concepts, and retain ...